BLCO Bausch + Lomb Corporation
$17.62▲ +0.23%
Healthcare
Other
After hours
$17.62▲ +0.00%
Oct 27, 5:05 PM ET
Volume 450.7K
Avg Volume (10D) 521.0K
Key Metrics & Fundamentals
Market Cap
$6.29B
P/E Ratio
–
Div Yield
0.00%
52W Range
14.44 - 18.92
% vs 50 MA
2.63%
% vs 200 MA
5.95%
RSI-14
60.2
MACD Histogram
+0.1300
Beta (1Y vs SPY)
0.95
Free Cash Flow
$82.00M
Gross Rev
$1.39B
Gross Profit
$867.00M
EBITDA
$209.00M
COGS
$527.00M
Operating Exp
$759.00M
Operating Income
$108.00M
EBIT
$108.00M
Pretax Income
-$11.00M
Net Income
-$14.00M
EPS (Diluted)
-0.04
Price & Volume History
Loading chart…
Recent News
Bausch + Lomb (BLCO) reports Q3: everything you need to know ahead of earnings
StockStory · Oct 27, 2026 7:18 AM ET
Bausch + Lomb (BLCO) Stock Looks Cheap After Its 13% Gain
Simply Wall St. · Oct 25, 2026 4:10 PM ET
Did CEO Exit Just Shift Bausch + Lomb (BLCO) Investment Narrative?
Simply Wall St. · Oct 25, 2026 3:07 PM ET
Bausch + Lomb (BLCO) Resets Leadership As Its Undervalued Narrative Faces A New Test
Simply Wall St. · Oct 25, 2026 2:09 PM ET
Forget Anthropic: Biotech Is Quietly Dominating the IPO Sphere
Barrons.com · Oct 24, 2026 2:57 PM ET
Billionaire Investor Took a Stake in Bausch + Lomb Before Its CEO Shake-Up
Benzinga · Oct 22, 2026 7:00 AM ET
3 Reasons BLCO is Risky and 1 Stock to Buy Instead
StockStory · Oct 16, 2026 12:27 PM ET
Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data
BioPharma Dive · Oct 12, 2026 8:09 AM ET
Bausch + Lomb Names Thomas Appio Interim CEO; Expects to Raise 2026 Guidance
MT Newswires · Oct 12, 2026 7:25 AM ET
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
Business Wire · Oct 12, 2026 6:45 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BLCO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.